Advertisement

ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract

      Cancer of the upper gastrointestinal (UGI) tract may develop in association with several underlying diseases. Surveillance of premalignant UGI conditions refers to endoscopic follow-up of individuals who are at increased risk for malignancy or in whom a neoplastic lesion has been identified and removed. The natural history of many of these premalignant conditions is not well characterized, and published surveillance data are limited by both lead-time and length-time bias. This guideline addresses the following conditions: Barrett's esophagus, achalasia, caustic ingestion, tylosis, upper aerodigestive tract cancer, gastric epithelial polyps, intestinal metaplasia of the stomach, pernicious anemia, postgastrectomy, familial adenomatous polyposis, and hereditary nonpolyposis colorectal cancer syndrome. This review updates the 1998 ASGE guideline on this subject.
      • American Society for Gastrointestinal Endoscopy
      The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Society for Gastrointestinal Endoscopy
        The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract.
        Gastrointest Endosc. 1998; 48: 663-668
        • Spechler S.J.
        Clinical practice. Barrett's esophagus.
        N Engl J Med. 2002; 346: 836-842
        • Sampliner R.E.
        Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.
        Am J Gastroenterol. 2002; 97: 1888-1895
        • Wang K.K.
        • Wongkeesong M.
        • Buttar N.S.
        American Gastroenterological Association medical position statement: role of the gastroenterologist in the management of esophageal carcinoma.
        Gastroenterology. 2005; 128: 1468-1470
        • Sharma P.
        • McQuaid K.
        • Dent J.
        • et al.
        A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop.
        Gastroenterology. 2004; 127: 310-330
        • Cooper G.S.
        • Yuan Z.
        • Chak A.
        • et al.
        Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia.
        Cancer. 2002; 95: 32-38
        • Kearney D.J.
        • Crump C.
        • Maynard C.
        • et al.
        A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD.
        Gastrointest Endosc. 2003; 57: 823-829
        • Corley D.A.
        • Levin T.R.
        • Habel L.A.
        • et al.
        Surveillance and survival in Barrett's adenocarcinomas: a population-based study.
        Gastroenterology. 2002; 122: 633-640
        • Bani-Hani K.
        • Sue-Ling H.
        • Johnston D.
        • et al.
        Barrett's oesophagus: results from a 13-year surveillance programme.
        Eur J Gastroenterol Hepatol. 2000; 12: 649-654
        • Anderson L.A.
        • Murray L.J.
        • Murphy S.J.
        • et al.
        Mortality in Barrett's oesophagus: results from a population based study.
        Gut. 2003; 52: 1081-1084
        • Rana P.S.
        • Johnston D.A.
        Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
        Dis Esophagus. 2000; 13: 28-31
        • Macdonald C.E.
        • Wicks A.C.
        • Playford R.J.
        Final results from a 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.
        BMJ. 2000; 321: 1252-1255
        • Conio M.
        • Blanchi S.
        • Lapertosa G.
        • et al.
        Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma (AC): a prospective study.
        Am J Gastroenterol. 2003; 98: 1931-1939
        • Provenzale D.
        • Schmitt C.
        • Wong J.B.
        Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
        Am J Gastroenterol. 1999; 94: 2043-2053
        • Inadomi J.M.
        • Sampliner R.
        • Lagergren J.
        • et al.
        Screening and surveillance for Barrett's esophagus in high-risk groups: A cost-utility analysis.
        Ann Intern Med. 2003; 138: 176-186
        • Gerson L.B.
        • Groeneveld P.W.
        • Triadafilopoulos G.
        Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
        Clin Gastroenterol Hepatol. 2004; 2: 868-879
        • Reid B.J.
        • Weinstein W.M.
        • Lewin K.J.
        • et al.
        Endoscopic biopsy can detect high-grade dsyplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
        Gastroenterology. 1988; 94: 81-90
        • Headrick J.R.
        • Nichols 3rd, F.C.
        • Miller D.L.
        • et al.
        High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy.
        Ann Thorac Surg. 2002; 73: 1697-1702
        • Buttar N.S.
        • Wang K.K.
        • Sebo T.J.
        • et al.
        Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.
        Gastroenterology. 2001; 120: 1630-1639
        • Dar M.S.
        • Goldblum J.R.
        • Rice T.W.
        • et al.
        Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?.
        Gut. 2003; 52: 486-489
        • Schnell T.G.
        • Sontag S.J.
        • Chejfec G.
        • et al.
        Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia.
        Gastroenterology. 2001; 120: 1607-1619
        • Johnston M.H.
        Technology insight: ablative techniques for Barrett's esophagus: current and emerging trends.
        Nat Clin Pract Gastroenterol Hepatol. 2005; 2: 323-330
        • Skacel M.
        • Petras R.E.
        • Gramlich T.L.
        • et al.
        The diagnosis of low-grade dsyplasia in Barrett's esophagus and its implications for disease progression.
        Am J Gastroenterol. 2000; 95: 3383-3387
        • Dulai G.S.
        • Shekelle P.G.
        • Jensen D.M.
        • et al.
        Dsyplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
        Am J Gastroenterol. 2005; 100: 775-783
        • Rudolph R.E.
        • Vaughan T.L.
        • Storer B.E.
        • et al.
        Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus.
        Ann Intern Med. 2000; 132: 612-620
        • Gopal D.V.
        • Lieberman D.O.
        • Magaret N.
        • et al.
        Risk factors for dysplasia in patients with Barrett's esophagus. Results from a multicenter consortium.
        Dig Dis Sci. 2003; 48: 1537-1541
        • Weston A.P.
        • Sharma P.
        • Mathur S.
        • et al.
        Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
        Am J Gastroenterol. 2004; 99: 1657-1666
        • Corey K.E.
        • Schmitz S.A.
        • Shaheen N.J.
        Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? a meta-analysis.
        Am J Gastroenterol. 2003; 98: 2390-2394
        • El-Serag H.B.
        • Aguirre T.V.
        • Davis S.
        • et al.
        Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.
        Am J Gastroenterol. 2004; 99: 1884-1886
        • Saeian K.
        • Staff D.M.
        • Vasilopoulos S.
        • et al.
        Unsedated transnasal endoscopy accurately detects Barrett's esophagus and dysplasia.
        Gastrointest Endosc. 2002; 56: 472-478
        • Canto M.I.F.
        • Setrakian S.
        • Willis J.
        • et al.
        Methylene-blue directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's eosphgagus.
        Gastrointest Endosc. 2000; 51: 560-568
        • Sharma P.
        • Weston A.P.
        • Topalovski M.
        • et al.
        Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
        Gut. 2003; 52: 24-27
        • Dave U.
        • Shousha S.
        • Westaby D.
        Methylene blue staining: Is it really useful in Barrett's esophagus?.
        Gastrointest Endosc. 2001; 53: 333-335
        • Egger K.
        • Werner M.
        • Meining A.
        • et al.
        Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques.
        Gut. 2003; 52: 18-23
        • Reid B.J.
        • Levine D.S.
        • Longton G.
        • et al.
        Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.
        Am J Gastroenterol. 2000; 95: 1669-1676
        • Faruqi S.A.
        • Arantes V.
        • Bhután M.S.
        Barrett's esophagus: current and future role of endosonography and optical coherencetomography.
        Dis Esophagus. 2004; 17: 118-123
        • Owens M.M.
        • Kimmey M.B.
        The role of endoscopic ultrasound in the diagnosis and management of Barrett's esophagus.
        Gastrointest Endosc Clin N Am. 2003; 13: 325-334
        • Eliakim R.
        • Sharma V.K.
        • Yassin K.
        • et al.
        A prospective study of the diagnostic accuracy of PillCam esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases.
        J Clin Gastroenterol. 2005; 39: 572-578
        • Ribeiro Jr., V.
        • Posner M.C.
        • Safatle-Ribeiro A.V.
        • et al.
        Risk factors for squamous cell carcinoma of the oesophagus.
        Br J Surg. 1996; 83: 1174-1185
        • Just-Viera J.O.
        • Haight C.
        Achalasia and carcinoma of the esophagus.
        Surg Gynecol Obstet. 1969; 128: 1081-1095
        • Wychulis A.R.
        • Woolman G.L.
        • Anderson H.A.
        • et al.
        Achalasia and carcinoma of the esophagus.
        JAMA. 1971; 215: 1638-1641
        • Peracchia A.
        • Segalin A.
        • Bardini R.
        • et al.
        Esophageal carcinoma and achalasia: prevalence, incidence, and results of treatment.
        Hepato-Gastroenterol. 1991; 38: 514-516
        • Meijssen M.A.C.
        • Tilanus H.W.
        • van Blankenstein M.
        • et al.
        Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients.
        Gut. 1992; 33: 155-159
        • Aggestrup S.
        • Holm J.C.
        • Sorensen H.R.
        Does achalasia predispose to cancer of the esophagus?.
        Chest. 1992; 102: 1013-1016
        • Sandler R.S.
        • Nyren O.
        • Ekborn A.
        • et al.
        The risk of esophageal cancer in patients with achalasia. A population-based study.
        JAMA. 1995; 274: 1359-1362
        • Streitz Jr., J.M.
        • Ellis Jr., F.H.
        • Gibb S.P.
        • et al.
        Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients.
        Ann Thorac Surg. 1995; 59: 1604-1609
        • Loviscek L.F.
        • Cenoz M.C.
        • Badaloni A.E.
        • et al.
        Early cancer in achalasia.
        Dis Esophagus. 1998; 11: 239-247
        • Brucher B.L.D.M.
        • Stein H.J.
        • Bartels H.
        • et al.
        Achalasia and esophageal cancer: incidence, prevalence, and prognosis.
        World J Surg. 2001; 25: 745-749
        • Chuong J.J.H.
        • DuBovik S.
        • McCallum R.W.
        Achalasia as a risk factor for esophageal carcinoma. A reappraisal.
        Dig Dis Sci. 1984; 29: 1105-1108
        • Dunaway P.M.
        • Wong R.K.H.
        Risk and surveillance intervals for squamous cell carcinoma in achalasia.
        Gastrointest Endoscopy Clin N Am. 2001; 11: 425-433
        • Ellis Jr., F.H.
        • Gibb S.P.
        • Balogh K.
        • et al.
        Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature.
        Dis Esophagus. 1997; 10: 55-60
        • Kiviranta U.K.
        Corrosion carcinoma of the esophagus.
        Acta Otolaryngol. 1952; 42: 89-95
        • Appelquist P.
        • Salmo M.
        Lye corrosion carcinoma of the esophagus. A review of 63 cases.
        Cancer. 1980; 45: 2655-2658
        • Hopkins R.A.
        • Postlethwait R.W.
        Caustic burns and carcinoma of the esophagus.
        Ann Surg. 1982; 194: 146-148
        • Isolauri J.
        • Markkula H.
        Lye ingestion and carcinoma of the esophagus.
        Acta Chir Scand. 1989; 155: 269-271
        • Bigelow N.H.
        Carcinoma of the esophagus developing at the site of lye stricture.
        Cancer. 1953; 6: 1159-1164
        • Imre J.
        • Kopp M.
        Argument against long-term conservative treatment of oesophageal strictures due to corrosive burns.
        Thorax. 1972; 27: 594-598
        • Howel-Evans W.
        • McConnell R.B.
        • Clarke C.A.
        • et al.
        Carcinoma of the esophagus with keratosis palmaris et plantaris (tylosis). A study of two families.
        Q J Med. 1958; 27: 413-429
        • Shine I.
        • Allison P.R.
        Carcinoma of the oesophagus with tylosis.
        Lancet. 1966; 1: 951-953
        • Harper P.S.
        • Harper R.M.J.
        • Howel-Evans A.W.
        Carcinoma of the esophagus with tylosis.
        Quart J Med. 1970; 39: 317-333
        • Marger R.S.
        • Marger D.
        Carcinoma of the esophagus and tylosis. A lethal combination.
        Cancer. 1993; 72: 17-19
        • Maillefer R.H.
        • Greydanus M.P.
        To B or not to B: is tylosis B truly benign?.
        Two North American genealogies. Am J Gastroenterol. 1999; 94: 829-834
        • Ashworth M.T.
        • Nash J.R.
        • Ellis A.
        • et al.
        Abnormalities of differentiation and maturation in the oesophageal squamous epithelium of patients with tylosis: morphological features.
        Histopathology. 1991; 19: 303-310
        • Cooper J.S.
        • Pajak T.
        • Rubin P.
        • et al.
        Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.
        Int J Radiat Oncol Biol Phys. 1989; 17: 449-456
        • Erkal H.S.
        • Mendenhall W.M.
        • Amdur R.J.
        • et al.
        Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites.
        J Clin Oncol. 2001; 19: 1358-1362
        • Atabek V.
        • Mohit-Tabatabai M.
        • Rush B.F.
        • et al.
        Impact of esophageal screening in patients with head and neck cancer.
        Am Surgeon. 1990; 56: 289-292
        • Shiozaki H.
        • Tahara H.
        • Kobayashi K.
        • et al.
        Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers.
        Cancer. 1990; 66: 2068-2071
        • Ina H.
        • Shibuya H.
        • Ohashi I.
        • et al.
        The frequency of concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer: screening results using Lugol dye endoscopy.
        Cancer. 1994; 73: 2038-2041
        • Tincani A.J.
        • Brandalise N.
        • Atemani A.
        • et al.
        Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer.
        Head Neck. 2000; 22: 170-174
        • Petit T.
        • Georges C.
        • Jung G.-M.
        • et al.
        Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma.
        Ann Oncol. 2001; 12: 643-646
        • Muto M.
        • Hironaka S.
        • Nakane M.
        • et al.
        Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
        Gastrointest Endoscopy. 2002; 56: 517-521
        • Scherubl H.
        • von Lampe B.
        • Faiss S.
        • et al.
        Screening for oesophageal neoplasia in patients with head and neck cancer.
        Br J Cancer. 2002; 86: 239-243
        • Shimizu Y.
        • Tukagoshi H.
        • Fujta M.
        • et al.
        Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers.
        Gastrointest Endosc. 2001; 53: 1-5
        • Choudhury U.
        • Boyce H.W.
        • Coppola D.
        Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics.
        Am J Pathol. 1998; 110: 615-621
        • Cristallini E.G.
        • Ascani S.
        • Bolis G.B.
        Association between histologic type of polyp and carcinoma in the stomach.
        Gastrointest Endosc. 1992; 38: 481-484
        • Rattan J.
        • Arber N.
        • Tiomny E.
        • et al.
        Gastric polypoid lesions: an eight year study.
        Hepato-Gastroenterology. 1993; 40: 107-109
        • Ginsberg G.G.
        • Al-Kawas F.H.
        • Fleishcher D.E.
        • et al.
        Gastric polyps: relationship of size and histology to cancer risk.
        Am J Gastroenterol. 1996; 91: 714-717
        • Daibo M.
        • Itabashi M.
        • Hirota T.
        Malignant transformation of gastric hyperplastic polyps.
        Am J Gastroenterol. 1987; 82: 1016-1025
        • Zea-Iriarte W.L.
        • Sekine I.
        • Itsuno M.
        • et al.
        Carcinoma in gastric hyperplastic poyps: a phenotypic study.
        Dig Dis Sci. 1996; 41: 377-386
        • Remmele W.
        • Kolb E.F.
        Malignant transformation of hyperplasiogenic polyps of the stomach.
        Endoscopy. 1978; 10: 63-65
        • Papa A.
        • Cammarota G.
        • Tursi A.
        • et al.
        Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study.
        Hepato-Gastroenterology. 1998; 45: 579-582
        • Seifert E.
        • Gail K.
        • Weismuller J.
        Gastric polypectomy: long-term results (survey of 23 centres in Germany).
        Endoscopy. 1983; 15: 8-11
        • Leung W.K.
        • Sung J.J.Y.
        Review article; intestinal metaplasia and gastric carcinogenesis.
        Aliment Pharmacol Ther. 2002; 16: 1209-1216
        • Whiting J.L.
        • Sigurdsson A.
        • Rowlands D.C.
        • et al.
        The long term results of endoscopic surveillance of premalignant gastric lesions.
        Gut. 2002; 50: 378-381
        • Rokkas T.
        • Filipe M.I.
        • Sladen G.E.
        Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.
        Gut. 1991; 32: 1110-1113
        • Lansdown M.
        • Quirke P.
        • Dixon M.F.
        • et al.
        High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma.
        Gut. 1990; 31: 977-983
        • DiGregorio C.
        • Morandi P.
        • Fante R.
        • et al.
        Gastric dysplasia. A follow-up study.
        Am J Gastroenterol. 1993; 88: 1714-1719
        • Farinari F.
        • Rugge M.
        • DiMario F.
        • et al.
        Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients: a prospective study.
        Endoscopy. 1993; 25: 261-264
        • Fertitta A.M.
        • Comin U.
        • Terruzzi V.
        • et al.
        Clinical significance of gastric dysplasia: a multicenter follow-up study.
        Endoscopy. 1993; 25: 265-268
        • Rugge M.
        • Leandro G.
        • Farinatti F.
        • et al.
        Gastric epithelial dysplasia: how clinicopathologic background relates to management.
        Cancer. 1995; 76: 376-382
        • Fennerty M.B.
        Gastric intestinal metaplasia on routine endoscopic biopsy.
        Gastroenterology. 2003; 125: 586-590
        • Kyrlagkitsis I.
        • Karamanolis D.G.
        Premalignant lesions and conditions for gastric adenocarcinoma: diagnosis, management, and surveillance guidelines.
        Hepato-Gastroenterology. 2003; 50: 592-600
        • Cassaro M.
        • Rugge M.
        • Gutierrez O.
        • et al.
        Topographic patterns of intestinal metaplasia and gastric cancer.
        Am J Gastroenterol. 2000; 95: 1431-1438
        • Chun-Yu Wong B.
        • Lam S.K.
        • Wong W.M.
        • et al.
        Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
        JAMA. 2004; 291: 187-194
        • Toh B.-H.
        • van Driel I.R.
        • Gleeson P.A.
        Pernicious anemia.
        N Engl J Med. 1997; 337: 1441-1448
        • Sjoblom S.M.
        • Sipponen P.
        • Jarvinen H.
        Gastroscopic follow up of pernicious anaemia patients.
        Gut. 1993; 34: 28-32
        • Elsborg L.
        • Mosbech J.
        Pernicious anemia as a risk factor in gastric cancer.
        Acta Med Scand. 1979; 206: 315-318
        • Brinton L.A.
        • Gridley G.
        • Hrubec Z.
        • et al.
        Cancer risk following pernicious anemia.
        Br J Cancer. 1989; 59: 810-813
        • Hsing A.W.
        • Hansson L.-E.
        • McLaughlin J.K.
        • et al.
        Pernicious anemia and subsequent cancer: a population based cohort study.
        Cancer. 1993; 71: 745-750
        • Mellemkjaer L.
        • Gridley G.
        • Moller H.
        • et al.
        Pernicious anaemia and cancer risk in Denmark.
        Br J Cancer. 1996; 73: 998-1000
        • Karlson B.-M.
        • Ekbom A.
        • Wacholder S.
        • et al.
        Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study.
        Scan J Gastroenterol. 2000; 35: 847-851
        • Ye W.
        • Nyren O.
        Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalized for pernicious anaemia.
        Gut. 2003; 52: 938-941
        • Schafer L.W.
        • Larson D.E.
        • Melton III, L.J.
        • et al.
        Risk of development of gastric carcinoma in patients with pernicious anemia: a population-based study in Rochester.
        Minnesota. Mayo Clin Proc. 1985; 60: 444-448
        • Armbrecht U.
        • Stockbrugger R.W.
        • Rode J.
        • et al.
        Development of gastric dysplasia in pernicious anemia: a clinical and endoscopic follow up study of 80 patients.
        Gut. 1990; 31: 1105-1109
        • Kokkola A.
        • Sjoblom S.-M.
        • Haapiainen R.
        • et al.
        The risk of gastric carcinoma and carcinoid tumors in patients with pernicious anemia: a prospective follow-up study.
        Scand J Gastroenterol. 1998; 33: 88-92
        • Lahner E.
        • Carvana P.
        • D'Ambra G.
        • et al.
        First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?.
        Gastrointest Endosc. 2001; 53: 443-448
        • Rindi G.
        • Luinetti O.
        • Cornaggia M.
        • et al.
        Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
        Gastroenterology. 1993; 104: 994-1006
        • Modlin I.M.
        • Lye K.D.
        • Kidd M.
        Carcinoid tumors of the stomach.
        Surg Oncol. 2003; 12: 153-172
        • Sculco D.
        • Bilgrami S.
        Pernicious anemia and gastric carcinoid tumor: case report and review.
        Am J Gastroenterol. 1997; 92: 1378-1380
        • Ichikawa J.
        • Tanabe S.
        • Koizumi W.
        • et al.
        Endoscopic mucosal resection in the management of gastric carcinoid tumors.
        Endoscopy. 2003; 35: 203-206
        • Hunt G.C.
        • Smith P.P.
        • Faigel D.O.
        Yield of tissue sampling for submucosal lesions evaluated by EUS.
        Gastrointest Endosc. 2003; 57: 68-72
        • Jordan Jr., P.H.
        • Barroso A.
        • Sweeney J.
        Gastric carcinoids in patients with hypergastrinemia.
        J Am Coll Surg. 2004; 199: 552-555
        • Helsingen N.
        • Hillestad L.
        Cancer development in the gastric stump after partial gastrectomy for ulcer.
        Ann Surg. 1956; 143: 173-179
        • Domellof L.
        • Janunger K.-G.
        The risk for gastric carcinoma after partial gastrectomy.
        Am J Surg. 1977; 134: 581-584
        • Schafer L.W.
        • Larson D.E.
        • Melton III, L.J.
        • et al.
        The risk of gastric carcinoma after surgical treatment for benign ulcer disease.
        N Engl J Med. 1983; 309: 1210-1213
        • Schuman B.M.
        • Waldbaum J.R.
        • Hiltz S.W.
        Carcinoma of the gastric remnant in a U.S. population.
        Gastrointest Endosc. 1984; 30: 71-73
        • Viste A.
        • Bjornestad E.
        • Opheim P.
        • et al.
        Risk of carcinoma following gastric operations for benign disease: a historical cohort study of 3740 patietns.
        Lancet. 1986; 2: 502-505
        • Lundergardh G.
        • Adami H.O.
        • Helmick C.
        Stomach cancer after partial gastrectomy for benign ulcer disease.
        N Engl J Med. 1988; 319: 195-200
        • Gandolfi L.
        • Vaira D.
        • Bertoni F.
        • et al.
        Cancer of the gastric stump in Italy, 1979-1986.
        Gastrointest Endosc. 1988; 34: 242-246
        • Greene F.L.
        Gastroscopic screening of the post-gastrectomy stomach: relationship of dysplasia to remnant cancer.
        Am Surg. 1989; 55: 12-15
        • Stael von Holstein C.
        • Eriksson S.
        • Huldt B.
        • et al.
        Endoscopic screening during 17 years for gastric stump carcinoma: a prospective clinical trial.
        Scand J Gastroenterol. 1991; 26: 1020-1026
        • Moller H.
        Toftgaard. Cancer occurrence in a cohort of patients surgically treated for peptic ulcer.
        Gut. 1991; 32: 740-744
        • Tersmette A.C.
        • Goodman S.N.
        • Offerhaus G.J.A.
        • et al.
        Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients.
        Am J Epidemiol. 1991; 134: 14-21
        • Safatle-Ribeiro A.V.
        • Ribeiro Jr., U.
        • Sakai P.
        • et al.
        Gastric stump mucosa: is there a risk for carcinoma?.
        Arq Gastroenterol. 2001; 38: 227-231
        • McLean Ross A.H.
        • Smith M.A.
        • Anderson J.R.
        • et al.
        Late mortality after surgery for peptic ulcer.
        N Engl J Med. 1982; 307: 519-522
        • Vecchia C.L.
        • Negri E.
        • D'Avanzo B.
        • et al.
        Partial gastrectomy and subsequent gastric cancer risk.
        J Epidemiol Community Health. 1992; 46: 12-14
        • Sarre R.G.
        • Frost A.G.
        • Jagelman D.G.
        • et al.
        Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature of upper gastrointestinal polyps.
        Gut. 1987; 28: 306-314
        • Spigelman A.D.
        • Williams C.B.
        • Talbot I.C.
        • et al.
        Upper gastrointestinal cancer in patients with familial adenomatous polyposis.
        Lancet. 1989; 2: 783-785
        • Church J.M.
        • McGannon E.
        • Hull-Boiner S.
        • et al.
        Gastroduodenal polyps in patients with familial adenomatous polyposis.
        Dis Colon Rectum. 1992; 35: 1170-1173
        • Offerhaus G.J.A.
        • Giardiello F.M.
        • Krush A.J.
        • et al.
        The risk of upper gastrointestinal cancer in familial adenomatous polyposis.
        Gastroenterology. 1992; 102: 1980-1982
        • Burke C.A.
        • Beck G.J.
        • Church J.M.
        • et al.
        The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program.
        Gastrointest Endosc. 1999; 49: 358-364
        • Heiskanen I.
        • Kellokumpu I.
        • Jarvinen H.
        Management of duodenal adenomas in 98 patients with familial adenomatous polyposis.
        Endoscopy. 1999; 31: 412-416
        • Kadmon M.
        • Tandara A.
        • Herfarth C.
        Duodenal adenomatosis in familial adenomatosis polyposis coli: a review of literature and results from the Heidelberg polyposis register.
        Int J Colorectal Dis. 2001; 16: 63-75
        • Bjork J.
        • Akerbrant H.
        • Iselius L.
        • et al.
        Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.
        Gastroenterology. 2001; 121: 1127-1135
        • Groves C.J.
        • Saunders B.P.
        • Spigelman A.D.
        • et al.
        Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.
        Gut. 2002; 50: 636-641
        • Morpurgo E.
        • Vitale G.C.
        • Galandiuk S.
        • et al.
        Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas.
        J Gastrointest Surg. 2004; 8: 559-564
        • Bulow S.
        • Bjork J.
        • Christensen I.J.
        • et al.
        Duodenal adenomatosis in familial adenomatous polyposis.
        Gut. 2004; 53: 381-386
        • Attard T.
        • Yardley J.
        • Cuffari C.
        Gastric polyps in pediatrics: An 18 year hospital based analysis.
        Am J Gastro. 2002; 97: 298-301
        • Zwick A.
        • Munir M.
        • Ryan C.K.
        • et al.
        Gastric adenocarcinoma and dypslasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli.
        Gastroenterol. 1997; 113: 659-663
        • Hofgartner W.T.
        • Thorp M.
        • Ramus M.W.
        • et al.
        Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis.
        Am J Gastroenterol. 1999; 94: 2275-2281
        • Nakamura S.
        • Matsumoto T.
        • Kobori Y.
        • et al.
        Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patient with familial adenomatous polyposis.
        Gut. 2002; 51: 485-489
        • Goedde T.A.
        • Rodriguez-Bigas M.A.
        • Herrera L.
        • et al.
        Gastroduodenal polyps in familial adenomatous polyposis.
        Surg Onc. 1992; 1: 357-361
        • Domizio R.
        • Talbot I.
        • Spigelman A.D.
        • et al.
        Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.
        J Clin Pathol. 1990; 43: 738-743
        • Jarvinen H.
        • Sipponen P.
        Gastroduodenal polyps in familial adenomatous polyposis and juvenile polyposis.
        Endoscopy. 1986; 18: 230-234
        • Jagelman D.G.
        • DeCosse J.J.
        • Bussey H.J.R.
        Leeds Castle Polyposis Group. Upper gastrointestinal cancer in familial adenomatous polyposis.
        Lancet. 1988; 1: 1149-1151
        • Abraham S.C.
        • Nobukawa B.
        • Giardiello F.M.
        • et al.
        Fundic gland polyps in familial adenomatous polyposis.
        Am J Pathol. 2000; 157: 747-754
        • Shimoyama S.
        • Aoki F.
        • Kawahara M.
        • et al.
        Early gastric cancer development in a familial adenomatous polyposis patient.
        Dig Dis Sci. 2004; 49: 260-265
        • Iida M.
        • Matsui T.
        • Itoh H.
        • et al.
        The value of push-type jejunal endoscopy in familial adenomatosis coli/Gardner's syndrome.
        Am J Gastroenterol. 1990; 85: 1346-1348
        • Bertoni G.
        • Sassatelli R.
        • Tansini P.
        • et al.
        Jejunal polyps in familial adenomatous polyposis assessed by push-type endoscopy.
        J Clin Gastroenterol. 1993; 17: 343-348
        • Burke C.A.
        • Santisi J.
        • Church J.
        • et al.
        The utility of capsule endoscopy small bowel surveillance in patients with polyposis.
        Am J Gastroenterology. 2005; 100: 1498-1502
        • Dalla Valle R.
        • Zinicola R.
        • Sianes M.
        • et al.
        Distal duodenal surveillance in familial adenomatous polyposis.
        Dig Liver Dis. 2004; 36: 557-560
        • Schulmann K.
        • Hollerbach S.
        • Kraus K.
        • et al.
        Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.
        Am J Gastroenterol. 2005; 100: 27-37
        • Matsumoto T.
        • Iida M.
        • Nakamura S.
        • et al.
        Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance.
        Am J Gastroenterol. 2000; 95: 1557-1562
        • Saurin J.-C.
        • Gutknecht C.
        • Napoleon B.
        • et al.
        Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease.
        J Clin Oncol. 2004; 22: 493-498
        • Vasen H.F.A.
        • Bulow S.
        • Myrhoj T.
        • et al.
        Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis.
        Gut. 1997; 40: 716-719
        • Johnson J.C.
        • DiSario J.A.
        • Grady W.M.
        Surveillance and treatment of periampullary and duodenal adenomas in familial adenomatous polyposis.
        Curr Treat Options Gastroenterol. 2004; 7: 79-89
        • Norton I.D.
        • Gostout C.J.
        • Baron T.H.
        • et al.
        Safety and outcome of endoscopic snare excision of the major duodenal papilla.
        Gastrointest Endosc. 2002; 56: 239-243
        • Catalano M.F.
        • Linder J.D.
        • Chak A.
        • et al.
        Endoscopic management of adenoma of the major duodenal papilla.
        Gastrointest Endosc. 2004; 59: 225-232
        • Penna C.
        • Phillips R.K.
        • Tiret E.
        • et al.
        Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centers.
        Br J Surg. 1993; 80: 1027-1029
        • Bleau B.L.
        • Gostout C.
        Endoscopic treatment of ampullary adenomas in familial adenomatous polyposis.
        J Clin Gastroenterol. 1996; 22: 237-241
        • Penna C.
        • Bataille N.
        • Balladur P.
        • et al.
        Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis.
        Br J Surg. 1998; 85: 665-668
        • Sarmiento J.M.
        • Thompson G.B.
        • Nagorney D.M.
        • et al.
        Pancreas-sparing duodenectomy for duodenal polyposis.
        Arch Surgery. 2002; 137: 557-563
        • Phillips R.K.S.
        • Wallace M.H.
        • Lynch P.M.
        • et al.
        A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
        Gut. 2002; 50: 857-860
        • Dunlop M.
        Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome.
        Gut. 2002; 51: 21-27
        • de Vos tot Nederveen Cappel W.H.
        • Järvinen H.J.
        • Björk J.
        • et al.
        Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis.
        Br J Surg. 2003; 90: 705-710
        • Watson P.
        • Lynch H.T.
        Extracolonic cancer in hereditary nonpolyposis colorectal cancer.
        Cancer. 1993; 71: 677-685
        • Aarnio M.
        • Salovaara R.
        • Aaltonen L.A.
        • et al.
        Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.
        Int J Cancer. 1997; 74: 551-555
        • Park Y.J.
        • Shin K.H.
        • Park J.G.
        Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
        Clinical Cancer Research. 2000; 6: 2994-2998
        • Renkonen-Sinisalo L.
        • Sipponen P.
        • Aarnio M.
        • et al.
        No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.
        Scand J Gastroenterol. 2002; 37: 574-577
        • Aarnio M.
        • Sankila R.
        • Pukkala E.
        • et al.
        Cancer risk in mutation carriers of DNA-mismatch repair genes.
        Int J Cancer. 1999; 81: 214-218
        • Schulman K.
        • Brasch F.E.
        • Kunstmann E.
        • et al.
        HNPCC-associated small bowel cancer: clinical and molecular characteristics.
        Gastroenterology. 2005; 128: 590-599